Scott William Drake

Scott William Drake, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in ViewRay, Inc., Paragon 28, Inc. and AtriCure, Inc. We count 16 filings; the first trade dates from 7 May 2021 and the latest from 18 July 2023.

On the open market, the record shows 2 purchases worth €539k and 1 sale worth €133k. The net balance comes to €406k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 12 share grants and 1 option exercise. Since January 2023: no purchases and 1 sale on the market.

The latest filing, published on 20 July 2023, reports an open-market sale of €133k in ViewRay, Inc. The clock since the last published purchase (12 May 2022) now reads 1,620 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.